| Literature DB >> 28411772 |
Helena Kuhn1, Constance Mennella2, Michelle Magid3, Caroline Stamu-O'Brien4, George Kroumpouzos5.
Abstract
Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.Entities:
Keywords: antidepressant; antipsychotic; cognitive-behavioral therapy; drug; management; pruritus; psychocutaneous; psychotherapy
Mesh:
Substances:
Year: 2017 PMID: 28411772 DOI: 10.1016/j.jaad.2016.11.021
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527